Background: Panic attacks affect a sizeable proportion of the population. The neurocircuitry of panic remains incompletely understood. Objective: To investigate the neuroanatomical underpinnings of panic attacks induced by deep brain stimulation (DBS) through (1) connectomic analysis of an obsessive-compulsive disorder patient who experienced panic attacks during inferior thalamic peduncle DBS; (2) appraisal of existing clinical reports on DBS-induced panic attacks. Methods: Panicogenic, ventral contact stimulation was compared with benign stimulation at other contacts using volume of tissue activated (VTA) modelling. Networks associated with the panicogenic zone were investigated using state-of-the-art normative connectivity mapping. In addition, a literature search for prior reports of DBS-induced panic attacks was conducted. Results: Panicogenic VTAs impinged primarily on the tuberal hypothalamus. Compared to nonpanicogenic VTAs, panicogenic loci were significantly functionally coupled to limbic and brainstem structures, including periaqueductal grey and amygdala. Previous studies found stimulation of these areas can also provoke panic attacks. Conclusions: DBS in the region of the tuberal hypothalamus elicited panic attacks in a single obsessivecompulsive disorder patient and recruited a network of structures previously implicated in panic pathophysiology, reinforcing the importance of the hypothalamus as a hub of panicogenic circuitry.
Introduction
Panic attacks are characterized by acute, sudden episodes of intense fearfulness and distress, accompanied by somatic symptoms such as chest palpitations, chest pain, dyspnea, sweating, lightheadedness, and paresthesias (DSM) [1] . When recurrent and spontaneous, such attacks define panic disorder, a debilitating and frequently comorbid anxiety disorder with a lifetime prevalence of 2e4% and a high incidence of treatment-resistance to mainstay pharmacological and behavioural therapies. Panic attacks can also manifest as isolated incidents outside of panic disorder, and up to 22% of the population experience panic in this way [2] . The neurocircuitry underpinning panic remains an area of active investigation, although converging insight from experimental animal model work [3, 4] , clinical case reports [5e13] , and functional neuroimaging studies [14] highlight the role of a distributed network of limbic, hypothalamic, and brainstem nodes in panic pathophysiology [15] .
Clinical case report
We report the case of a 25-year-old female with a 17-year history of severe refractory obsessive-compulsive disorder (OCD) who received bilateral inferior thalamic peduncle (ITP) DBS in 2010 at Toronto Western Hospital, University Health Network (REB #C-09-06). The patient had a pre-operative baseline score of 34 on the Yale-Brown Obsessive Compulsive Scale (YBOCS) with symptoms primarily defined by checking behaviours and a baseline score of 14 on the Hamilton Rating Scale for Depression-17 Item (HAM-D17). She had no history of panic attacks. The patient's pre-operative medications comprised paroxetine (60 mg), risperidone (0.5 mg), lorazepam (1 mg), and olanzapine (15 mg). She was educated at the high school level and was receiving disability payments due to her condition prior to surgery.
Following informed consent to surgery, the patient underwent inferior thalamic peduncle (ITP) DBS as previously described [16] . First, a T1-weighted three-dimensional spoiled gradient echo (3D-SPGR) MRI scan (General Electric Signa Excite 1.5T scanner, voxel size 1 Â 1 Â 1 mm, TR 12.4 ms, TE 5.3 ms, flip angle 20 ) was acquired for stereotactic planning. Quadripolar stimulating electrodes (St. Jude 6143) were then inserted in the usual fashion under fluoroscopic guidance. To test for acute mood or anxiety changes, intra-operative macrostimulation was delivered at each electrode. The electrodes were subsequently internalized and connected to an implantable pulse generator (IPG: St. Jude LibraXP). On postoperative day one, the patient received a second 3D-SPGR MRI (General Electric Signa Excite 1.5T scanner, voxel size 1 Â 1 Â 1 mm, TR 11.9 ms, TE 5.0 ms, flip angle 20 ) to confirm electrode location before being discharged with the DBS system turned off. There were no adverse effects during or immediately following surgery.
Approximately one-month post-operatively, the patient returned to clinic for initial stimulation testing. Stimulation was delivered through each of the four contacts. Clinical effects were tested by a single psychiatrist (PG) using monopolar stimulation parameters (amperes: 1e4 mA, frequency: 130 Hz, pulse width: 91 ms). Bilateral monopolar stimulation of the deepest contacts (Cþ1-, Cþ9-) with these parameters reproducibly triggered panic attacks on three occasions. Each episode began within 5e10 s of activating the most ventral contacts; the patient reported an immediate subjective feeling of elevated heart rate and a sensation of heat in her head and neck, followed by sweating and subsequently by acute anxiety. This was accompanied by a concern that she was physically unwell; no other cognitive distortions were noted. Ventral contact stimulation was turned off within 15e30 s, leading to a major reduction in all symptoms within 60 s. Symptoms fully resolved without additional medication within 20 min of deactivation of the device. Stimulation through other contacts failed to elicit panic attacks or any other adverse effects. Alternative therapeutic stimulation settings were therefore selected using more dorsal contacts; these were adjusted in subsequent programming sessions based on clinical feedback.
In the months following initial DBS programming, the patient's obsessions and compulsions improved markedly, decreasing from 10 to 12 h/day to 2 h/day. At her one-year post-operative visit, during which time she was using stimulation at the second most dorsal electrode contacts (DBS settings: Cþ3-, Cþ11-, 8.5 mA, 130 Hz, 91 ms), the patient's YBOCS score had decreased to 19 (44.1% improvement from pre-operative baseline). Similarly, her HAM-D17 score was reduced to 4 (71.4% improvement from preoperative baseline). She was taking paroxetine (30 mg), risperidone (2 mg), and lorazepam (1 mg). The patient has continued to experience sustained clinical benefit from DBS and has undergone multiple battery changes. She has not had any further DBS-related adverse effects. At last follow-up approximately eight-years postoperatively (DBS settings: Cþ4-, Cþ12-, 8 mA, 130 Hz, 91 ms), her YBOCS score was 20 and her HAM-D17 score was 2. Her medications at this time were clomipramine (300 mg), aripiprazole (6 mg), and lorazepam (1 mg).
Imaging analysis
Electrode localization and volume of tissue activated (VTA) modelling DBS electrode localization and volume of tissue activated (VTA) modelling were conducted in Lead-DBS (https://www.leaddbs.org/) [17] . Briefly, the post-operative MRI scan was rigidly registered to the pre-operative stereotactic MRI scan and the DBS electrodes were manually localized as mutually agreed on by two experienced users (GJBE and AB). Both pre-and post-operative images along with the electrodes themselves were subsequently normalized to MNI space (Fig. 1a) . Post-operative brain shift was addressed with a subcortical refine transform in Lead-DBS. The VTA associated with each stimulation setting was modelled using the FieldTrip-SimBio finite element model pipeline with 0.2V/mm thresholding in Lead-DBS. Peri-electrode brain tissue was classified as white or grey matter according to the Distal subcortical atlas and assigned differing conductivity values (0.14 S/mm and 0.33 S/mm, respectively) [18] . For the purposes of this analysis, we modelled the panicogenic settings at the time of DBS programming (Cþ1-, Cþ9-, 3.5 mA), as well as the therapeutic settings at one (Cþ3-, Cþ11-, 8.5 mA) and eight years (Cþ4-, Cþ12-, 8 mA).
Hypothalamic atlas overlay
To investigate the spatial relationship between DBS and specific hypothalamic nuclei, the panicogenic VTAs were overlaid with a segmented hypothalamic atlas in MNI space [19] . Bilaterally, the VTAs markedly impinged on the tuberal hypothalamus. The dorsomedial hypothalamus and lateral hypothalamic area showed the greatest degree of overlap with the VTAs (Fig. 1b) . There was minimal overlap between the panicogenic VTAs and nonpanicogenic VTAs, which did not touch the hypothalamus.
Functional network connectomic analysis
The panicogenic and therapeutic VTAs were utilized as 2 Â 2x2 mm seeds for functional connectomic analysis using a normative resting state fMRI (rsfMRI) dataset derived from 1000 healthy Brain Genomics Superstruct Project subjects (http:// neuroinformatics.harvard.edu/gsp/) [20] . To identify brain regions preferentially connected to the panicogenic seed, voxelwise difference maps (panic vs. one-year follow-up; panic vs. eight-year follow-up) comparing the panicogenic connectivity map to each of the therapeutic connectivity maps were created. Paired t-tests found that the panicogenic connectivity map differed significantly from both therapeutic connectivity maps (p < 0.001). Spatial differences between panicogenic and therapeutic maps were discerned by first transforming each difference map's r values to zscores; p-values adjusted for multiple comparisons were then derived for each voxel. Each difference z-map was thresholded by p < 0.05 (FDR-corrected) and the two thresholded maps were then combined, taking the highest value at each voxel. Positive and negative z-maps were segregated to appreciate correlated and anti-correlated networks, respectively. Brain areas outside the hypothalamus that significantly correlated with panic included periaqueductal/periventricular grey, right amygdala, and bilateral cortical regions including frontal pole, subcallosal cingulate cortex, orbitofrontal cortex, and temporal pole. By contrast, the right posterior hippocampus and bilateral cerebral peduncles, thalamus, striatum, and anterior/posterior cingulate, and paracingulate cortices were significantly anti-correlated with panic (Fig. 1c) .
Literature search
To identify prior clinical reports on DBS-induced panic attacks, a literature search for peer-reviewed articles in the NCBI Pubmed database was conducted. The search terms 'deep brain stimulation', 'DBS', 'electrical stimulation', 'panic', and 'anxiety' were employed. In total, nine clinical case reports were found to describe stimulation-induced panic in the context of DBS or other procedures involving depth electrodes. These involved patients with a range of psychiatric and non-psychiatric conditions and encompassed a variety of anatomical targets (Table 1) [5e13,21].
Discussion
These clinical and neuroimaging findings suggest that electrical stimulation delivered in the vicinity of the tuberal hypothalamus can trigger panic attacks, possibly by engaging a panicogenic network of limbic and brainstem structures. Although derived from a single case study, this pattern of results contributes to our understanding of panic by further elucidating the circuitry of this phenomenon and reinforcing its susceptibility to modulation in a clinical context. Prevalent theories of panic pathophysiology suggest panic attacks are driven by a fear-implicated network centred on the amygdala and also comprising hypothalamus, hippocampus, several brainstem structures, and medial prefrontal cortex [15] . Hypersensitivity and subsequent overactivation of this putative network is proposed to give rise to the distinct constellation of symptoms seen in panic, with each subcortical region contributing to a particular component (e.g., amygdala instantiating acute fearfulness, periaqueductal grey recruiting behavioural 'fight-or-flight' responses, locus coeruleus regulating alertness and arousal levels, and tuberal hypothalamus activating the sympathetic nervous system and neuroendocrine secretions) [15] . Sensory, affective, and cognitive inputs to amygdala from distributed cortical areas are also understood to play a role in triggering panic, although it is possible that direct engagement of certain subcortical elements may be sufficient to jump-start the response. Indeed, animal models demonstrate that 'escape behaviour' (frantic running and jumping) and other panic surrogates can be consistently induced by electrically stimulating the amygdala, dorsal periaqueductal grey (dPAG), or ventromedial hypothalamus (VMH) [3, 4] . These findings suggest that the network may be activated via electrical modulation at various subcortical nodes, indicating a degree of multidirectional information flow and reactivity. Interestingly, our connectome results found these same areas were preferentially functionally interconnected with the hypothalamic stimulation locus.
Consistent with the animal literature, electrical stimulation of amygdala [7] , dPAG [8] , and/or hypothalamus [5, 11] appears sufficient to provoke panic attacks in patients. Panic has also been reported in the context of nucleus accumbens (NAc) DBS, particularly when the most ventral contacts are stimulated [6, 12, 13] ; this might reflect current spread to the nearby hypothalamus or hypothalamic afferents, or could alternatively relate to NAc's role as a hub for limbic projections from areas such as cingulate cortex, amygdala, and hippocampus [22] . One prior study reported panic symptoms with ITP DBS when the lowest contacts e putatively located in VMH e were stimulated [21] . Importantly, these reports include both psychiatric and non-psychiatric patients, suggesting electrical induction of panic is a generalizable phenomenon. While the panic literature has focused mostly on VMH, this case illustrates panicogenesis through preferential stimulation of the lateral hypothalamic area (LHA) and dorsomedial hypothalamus (DMH). Much like VMH, which is tightly coupled with amygdala and dPAG [5, 6] , DMH has extensive connectivity with amygdala, PAG, VMH, and the hypothalamic paraventricular nucleus, which regulates the hypothalamic-pituitary-adrenal axis [23] . As such, DMH may be well-positioned to recruit other putative panic hubs and drive related behaviour.
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